Potentiation of mammary cancer inhibition by combination of antagonists of growth hormone-releasing hormone with docetaxel

Antagonists of growth hormone-releasing hormone (GHRH) are being developed for the treatment of various cancers. In this study, we investigated the effectiveness of treatment with GHRH antagonist JMR-132 alone and in combination with docetaxel chemotherapy in nude mice bearing MX-1 human breast canc...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Buchholz, Stefan, Schally, Andrew V., Engel, Jörg B., Hohla, Florian, Heinrich, Elmar, Koester, Frank, Varga, Jozsef L., Halmos, Gabor
Format: Artigo
Jezik:Inglês
Izdano: National Academy of Sciences 2007
Teme:
Biological Sciences
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC1794297/
https://ncbi.nlm.nih.gov/pubmed/17261802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0610860104
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki